HomeCompareTRONW vs PFE

TRONW vs PFE: Dividend Comparison 2026

TRONW yields 4065.04% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TRONW wins by $8383345271821.52M in total portfolio value
10 years
TRONW
TRONW
● Live price
4065.04%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8383345271821.57M
Annual income
$7,996,384,829,748,816,000.00
Full TRONW calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — TRONW vs PFE

📍 TRONW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTRONWPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TRONW + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TRONW pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TRONW
Annual income on $10K today (after 15% tax)
$345,528.46/yr
After 10yr DRIP, annual income (after tax)
$6,796,927,105,286,493,000.00/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, TRONW beats the other by $6,796,927,105,286,471,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TRONW + PFE for your $10,000?

TRONW: 50%PFE: 50%
100% PFE50/50100% TRONW
Portfolio after 10yr
$4191672635910.81M
Annual income
$3,998,192,414,874,421,000.00/yr
Blended yield
95.38%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

TRONW
No analyst data
Altman Z
7.2
Piotroski
2/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TRONW buys
0
PFE buys
0
No recent congressional trades found for TRONW or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTRONWPFE
Forward yield4065.04%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$8383345271821.57M$49.6K
Annual income after 10y$7,996,384,829,748,816,000.00$26,258.71
Total dividends collected$8356966171072.82M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TRONW vs PFE ($10,000, DRIP)

YearTRONW PortfolioTRONW Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$417,204$406,504.07$9,153$693.39+$408.1KTRONW
2$16,296,422$15,850,013.87$8,593$849.25+$16.29MTRONW
3$596,052,062$578,614,890.14$8,336$1,066.78+$596.04MTRONW
4$20,416,476,221$19,778,700,514.38$8,437$1,384.80+$20416.47MTRONW
5$655,001,400,109$633,155,770,552.78$9,013$1,875.40+$655001.39MTRONW
6$19,684,873,685,924$18,984,022,187,807.58$10,306$2,680.72+$19684873.68MTRONW
7$554,268,607,828,726$533,205,792,984,787.70$12,820$4,101.38+$554268607.82MTRONW
8$14,624,393,933,143,850$14,031,326,522,767,112.00$17,673$6,826.70+$14624393933.13MTRONW
9$361,645,272,965,188,740$345,997,171,456,724,800.00$27,543$12,591.86+$361645272965.16MTRONW
10$8,383,345,271,821,568,000$7,996,384,829,748,816,000.00$49,560$26,258.71+$8383345271821.52MTRONW

TRONW vs PFE: Complete Analysis 2026

TRONWStock

Corner Growth Acquisition Corp. 2 is a blank check company created for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on February 10, 2021 and is headquartered in Palo Alto, CA.

Full TRONW Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this TRONW vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TRONW vs SCHDTRONW vs JEPITRONW vs OTRONW vs KOTRONW vs MAINTRONW vs JNJTRONW vs MRKTRONW vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.